EBERS’ CEO, Pedro Moreo, participated in the EIC-EVONIK Corporate Day that took place in the headquarters of Evonik in Essen on February 6, co-organized by the European Innovation Council and Evonik. It was a great opportunity to present the new organ preservation technology that EBERS is developing to representatives of the Health Care division and the corporate venture capital fund of Evonik and discuss about the technology and potential collaborations.
EBERS has recently reached a distribution agreement with AR Brown Co., Ltd. EBERS products will be available in Japan from now on.
Check our distributors section for contact details!
The ebers team.
EBERS has been recently awarded by the European Comission with a SME-Phase II project that will grant the company with 2.6M€ for the certification and clinical validation of our organ preservation device.
These are good very news indeed ;)
We take this opportunity to wish you Merry Xmas and a happy new year!
The EBERS team.